{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:53:23Z","timestamp":1770911603839,"version":"3.50.1"},"reference-count":55,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2024-0017_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate the implementation, compliance, and impact of the enhanced recovery after surgery (ERAS) protocol on perioperative outcomes in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for Stage IIIc ovarian cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2024-0017_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From September 2020 to March 2022, the ERAS protocol (62 perioperative and special consideration guidelines) was prospectively implemented in 75 patients. Based on compliance rates, patients were divided into three groups: Group A (&lt;70\u202f%, 13 patients), Group B (70\u202f%\u201380\u202f%, 52 patients), and Group C (&gt;80\u202f%, 10 patients). Compliance rates, length of stay, postoperative complications, and readmission rates were analyzed. Ethical committee approval was obtained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2024-0017_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The cohort\u2019s average compliance was 74.5\u202f%, with group averages of 68.4\u202f%, 74.4\u202f%, and 82.5\u202f% (p&lt;0.001). Tolerance to normal diet (p=0.008), postoperative ileus (p=0.161), and mobilization rates (p&lt;0.001) improved with higher compliance. Higher compliance also led to shorter hospital stays (p=0.008) and ICU stays (p&lt;0.001). Complications like ileus and infections were lowest in Group C. No significant differences were found in re-surgery or mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2024-0017_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Implementation of the ERAS protocol in patients undergoing CRS and HIPEC for Stage IIIc ovarian cancer is feasible and associated with improved postoperative outcomes. Higher compliance with ERAS guidelines significantly reduced length of hospital and ICU stay, enhanced early mobilization, and improved tolerance to diet, while also decreasing postoperative complications. Compliance above 80\u202f% is necessary for achieving optimal outcomes and protocol modifications may improve compliance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2024-0017","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T05:58:26Z","timestamp":1746424706000},"page":"89-98","source":"Crossref","is-referenced-by-count":3,"title":["Optimizing patient recovery: prospective study evaluating compliance and clinical outcomes of enhanced recovery protocols in ovarian cancer following cytoreductive surgery with HIPEC"],"prefix":"10.1515","volume":"10","author":[{"given":"S. P.","family":"Somashekhar","sequence":"first","affiliation":[{"name":"Aster International Institute of Oncology Consultant \u2013 Surgical Oncologist Aster Hospital CMI , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar C.","family":"Rohit","sequence":"additional","affiliation":[{"name":"Consultant Surgical Oncologist, Aster Whitefield Hospital , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Aster CMI Hospital , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Ahuja","sequence":"additional","affiliation":[{"name":"Gynecological Oncology , Aster Whitefield Hospital , Bangalore , Karnataka , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kushal","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Surgical Oncology , Aster Whitefield Hospital , Bangalore , Karnataka , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5768-9326","authenticated-orcid":false,"given":"Esha","family":"Shanbhag","sequence":"additional","affiliation":[{"name":"Gynecological Oncology , Aster Whitefield Hospital , Bangalore , Karnataka , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7219-1155","authenticated-orcid":false,"given":"K. R.","family":"Ashwin","sequence":"additional","affiliation":[{"name":"Consultant Surgical Oncologist, Aster Whitefield Hospital , Bangalore , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"2025120909254757897_j_pp-2024-0017_ref_001","doi-asserted-by":"crossref","unstructured":"van Driel, WJ, Koole, SN, Sikorska, K, Schagen van Leeuwen, JH, Schreuder, HW, Hermans, RH, et al.. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N\u00a0Engl J Med 2018;378:230\u201340. https:\/\/doi.org\/10.1056\/NEJMoa1708618.","DOI":"10.1056\/NEJMoa1708618"},{"key":"2025120909254757897_j_pp-2024-0017_ref_002","doi-asserted-by":"crossref","unstructured":"Bakrin, N, Bereder, JM, Msika, S, Lorimier, G. FROGHI (FRench Oncologic and Gynecologic HIPEC) Group. Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol 2013;39:1435\u201343. https:\/\/doi.org\/10.1016\/j.ejso.2013.09.030.","DOI":"10.1016\/j.ejso.2013.09.030"},{"key":"2025120909254757897_j_pp-2024-0017_ref_003","doi-asserted-by":"crossref","unstructured":"Cascales-Campos, PA, Gil, J, Gil, E, Feliciangeli, E, Gonz\u00e1lez-Gil, A, Parrilla, JJ, et al.. Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC\/IV ovarian cancer. Ann Surg Oncol 2014;21:2383\u20139. https:\/\/doi.org\/10.1245\/s10434-014-3599-4.","DOI":"10.1245\/s10434-014-3599-4"},{"key":"2025120909254757897_j_pp-2024-0017_ref_004","doi-asserted-by":"crossref","unstructured":"Cascales-Campos, P, L\u00f3pez-L\u00f3pez, V, Gil, J, Ar\u00e9valo-P\u00e9rez, J, Nieto, A, Barcel\u00f3, F, et al.. Hyperthermic intraperitoneal chemotherapy with paclitaxel or cisplatin in patients with stage III-C\/IV ovarian cancer: is there any difference? Surg Oncol 2016;25:164\u201370. https:\/\/doi.org\/10.1016\/j.suronc.2016.05.010.","DOI":"10.1016\/j.suronc.2016.05.010"},{"key":"2025120909254757897_j_pp-2024-0017_ref_005","doi-asserted-by":"crossref","unstructured":"Di Giorgio, A, De Iaco, P, De Simone, M, Garofalo, A, Scambia, G, Pinna, AD, et al.. Cytoreduction (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: retrospective Italian multicenter observational study of 511 cases. Ann Surg Oncol 2017;24:914\u201322. https:\/\/doi.org\/10.1245\/s10434-016-5686-1.","DOI":"10.1245\/s10434-016-5686-1"},{"key":"2025120909254757897_j_pp-2024-0017_ref_006","doi-asserted-by":"crossref","unstructured":"Zhang, G, Zhu, Y, Liu, C, Chao, G, Cui, R, Zhang, Z. The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis. J\u00a0Ovarian Res 2019;12:33. https:\/\/doi.org\/10.1186\/s13048-019-0509-1.","DOI":"10.1186\/s13048-019-0509-1"},{"key":"2025120909254757897_j_pp-2024-0017_ref_007","doi-asserted-by":"crossref","unstructured":"Armstrong, DK, Alvarez, RD, Bakkum-Gamez, JN, Barroilhet, L, Behbakht, K, Berchuck, A, et al.. NCCN guidelines insights: ovarian cancer, version 1. 2019. J\u00a0Natl Compr Cancer Netw 2019;17:896\u2013909. https:\/\/doi.org\/10.6004\/jnccn.2019.0039.","DOI":"10.6004\/jnccn.2019.0039"},{"key":"2025120909254757897_j_pp-2024-0017_ref_008","doi-asserted-by":"crossref","unstructured":"Somashekhar, SP, Rohit, KC, Deo, SVS, Ashwin, KR. Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM). Pleura Peritoneum 2020;5:20200120. https:\/\/doi.org\/10.1515\/pp-2020-0120.","DOI":"10.1515\/pp-2020-0120"},{"key":"2025120909254757897_j_pp-2024-0017_ref_009","doi-asserted-by":"crossref","unstructured":"Elias, D, Goere, D, Blot, F, Billard, V, Pocard, M, Kohneh-Shahri, N, et al.. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients. Ann Surg Oncol 2007;14:1818\u201324. https:\/\/doi.org\/10.1245\/s10434-007-9348-1.","DOI":"10.1245\/s10434-007-9348-1"},{"key":"2025120909254757897_j_pp-2024-0017_ref_010","doi-asserted-by":"crossref","unstructured":"Kusamura, S, Younan, R, Baratti, D, Costanzo, P, Favaro, M, Gavazzi, C, et al.. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006;106:1144\u201353. https:\/\/doi.org\/10.1002\/cncr.21708.","DOI":"10.1002\/cncr.21708"},{"key":"2025120909254757897_j_pp-2024-0017_ref_011","doi-asserted-by":"crossref","unstructured":"Ceelen, WP, Peeters, M, Houtmeyers, P, Breusegem, C, De Somer, F, Pattyn, P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Ann Surg Oncol 2008;15:535\u201341. https:\/\/doi.org\/10.1245\/s10434-007-9648-5.","DOI":"10.1245\/s10434-007-9648-5"},{"key":"2025120909254757897_j_pp-2024-0017_ref_012","doi-asserted-by":"crossref","unstructured":"Desantis, M, Bernard, J-L, Casanova, V, Cegarra-Escolano, M, Benizri, E, Rahili, AM, et al.. Morbidity, mortality, and oncological outcomes of 401 consecutive cytoreductive procedures with hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg 2015;400:37\u201348. https:\/\/doi.org\/10.1007\/s00423-014-1253-z.","DOI":"10.1007\/s00423-014-1253-z"},{"key":"2025120909254757897_j_pp-2024-0017_ref_013","doi-asserted-by":"crossref","unstructured":"Ljungqvist, O, Scott, M, Fearon, KC. Enhanced recovery after surgery: a review. JAMA Surg 2017;152:292\u20138. https:\/\/doi.org\/10.1001\/jamasurg.2016.4952.","DOI":"10.1001\/jamasurg.2016.4952"},{"key":"2025120909254757897_j_pp-2024-0017_ref_014","doi-asserted-by":"crossref","unstructured":"Kehlet, H. Fast-track colorectal surgery. Lancet 2008;371:791\u20133. https:\/\/doi.org\/10.1016\/s0140-6736(08)60357-8.","DOI":"10.1016\/S0140-6736(08)60357-8"},{"key":"2025120909254757897_j_pp-2024-0017_ref_015","doi-asserted-by":"crossref","unstructured":"ERAS Compliance Group. The impact of enhanced recovery protocol compliance on elective colorectal cancer resection: results from an international registry. Ann Surg 2015;261:1153\u20139. https:\/\/doi.org\/10.1097\/SLA.0000000000001029.","DOI":"10.1097\/SLA.0000000000001029"},{"key":"2025120909254757897_j_pp-2024-0017_ref_016","doi-asserted-by":"crossref","unstructured":"Wijk, L, Udumyan, R, Pache, B, Altman, AD, Williams, LL, Elias, KM, et al.. International validation of Enhanced Recovery after Surgery Society guidelines on enhanced recovery for gynecologic surgery. Am J Obstet Gynecol 2019;221:237 e1ee11. https:\/\/doi.org\/10.1016\/j.ajog.2019.04.02.","DOI":"10.1016\/j.ajog.2019.04.028"},{"key":"2025120909254757897_j_pp-2024-0017_ref_017","doi-asserted-by":"crossref","unstructured":"Khoo, CK, Vickery, CJ, Forsyth, N, Vinall, NS, Eyre-Brook, IA. A prospective randomized controlled trial of multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer. Ann Surg 2007;245:867\u201372. https:\/\/doi.org\/10.1097\/01.sla.0000259219.08209.36.","DOI":"10.1097\/01.sla.0000259219.08209.36"},{"key":"2025120909254757897_j_pp-2024-0017_ref_018","doi-asserted-by":"crossref","unstructured":"Muller, S, Zalunardo, MP, H\u00fcbner, M, Clavien, PA, Demartines, N. Zurich fast track study group, A fast-track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology 2009;136:842\u20137. https:\/\/doi.org\/10.1053\/j.gastro.2008.10.030.","DOI":"10.1053\/j.gastro.2008.10.030"},{"key":"2025120909254757897_j_pp-2024-0017_ref_019","doi-asserted-by":"crossref","unstructured":"Miralpeix, E, Nick, AM, Meyer, LA, Cata, J, Lasala, J, Mena, GE, et al.. A call for new standard of care in perioperative gynecologic oncology practice: impact of enhanced recovery after surgery (ERAS) programs. Gynecol Oncol 2016;141:371\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2016.02.019.","DOI":"10.1016\/j.ygyno.2016.02.019"},{"key":"2025120909254757897_j_pp-2024-0017_ref_020","doi-asserted-by":"crossref","unstructured":"Wijk, L, Udumyan, R, Pache, B, Altman, AD, Williams, LL, Elias, KM, et al.. International validation of enhanced recovery after surgery society guidelines on enhanced recovery for gynecologic surgery. Am J Obstet Gynecol 2019;221:237 e1ee11. https:\/\/doi.org\/10.1016\/j.ajog.2019.04.028.","DOI":"10.1016\/j.ajog.2019.04.028"},{"key":"2025120909254757897_j_pp-2024-0017_ref_021","doi-asserted-by":"crossref","unstructured":"P\u0119dziwiatr, M, Kisialeuski, M, Wierdak, M, Stanek, M, Natkaniec, M, Mat\u0142ok, M, et al.. Early implementation of enhanced recovery after surgery (ERAS\u00ae) protocol\u00a0\u2013\u00a0compliance improves outcomes: a prospective cohort study. Int J Surg 2015;21:75\u201381. https:\/\/doi.org\/10.1016\/j.ijsu.2015.06.087.","DOI":"10.1016\/j.ijsu.2015.06.087"},{"key":"2025120909254757897_j_pp-2024-0017_ref_022","doi-asserted-by":"crossref","unstructured":"H\u00fcbner, M, Kusamura, S, Villeneuve, L, Al-Niaimi, A, Alyami, M, Balonov, K, et al.. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations\u00a0\u2013\u00a0Part II: postoperative management and special considerations. Eur J Surg Oncol 2020;46:2311\u201323. https:\/\/doi.org\/10.1016\/j.ejso.2020.08.006.","DOI":"10.1016\/j.ejso.2020.08.006"},{"key":"2025120909254757897_j_pp-2024-0017_ref_023","doi-asserted-by":"crossref","unstructured":"H\u00fcbner, M, Kusamura, S, Villeneuve, L, Al-Niaimi, A, Alyami, M, Balonov, K, et al.. Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic intraperitoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations\u00a0\u2013\u00a0Part I: preoperative and intraoperative management. Eur J Surg Oncol 2020;46:2292\u2013310. https:\/\/doi.org\/10.1016\/j.ejso.2020.07.041.","DOI":"10.1016\/j.ejso.2020.07.041"},{"key":"2025120909254757897_j_pp-2024-0017_ref_024","doi-asserted-by":"crossref","unstructured":"Maessen, J, Dejong, CH, Hausel, J, Nygren, J, Lassen, K, Andersen, J, et al.. A protocol is not enough to implement an enhanced recovery programme for colorectal resection. Br J Surg 2007;94:224\u201331. https:\/\/doi.org\/10.1002\/bjs.5468.","DOI":"10.1002\/bjs.5468"},{"key":"2025120909254757897_j_pp-2024-0017_ref_025","doi-asserted-by":"crossref","unstructured":"Kahokehr, A, Sammour, T, Zargar-Shoshtari, K, Thompson, L, Hill, AG. Implementation of ERAS and how to overcome the barriers. Int J Surg 2009;7:16\u20139. https:\/\/doi.org\/10.1016\/j.ijsu.2008.11.004.","DOI":"10.1016\/j.ijsu.2008.11.004"},{"key":"2025120909254757897_j_pp-2024-0017_ref_026","doi-asserted-by":"crossref","unstructured":"P\u0119dziwiatr, M, Kisialeuski, M, Wierdak, M, Stanek, M, Natkaniec, M, Mat\u0142ok, M, et al.. Early implementation of Enhanced Recovery after Surgery (ERAS\u00ae) protocol\u00a0\u2013\u00a0compliance improves outcomes: a prospective cohort study. Int J Surg 2015;21:75\u201381. https:\/\/doi.org\/10.1016\/j.ijsu.2015.06.087.","DOI":"10.1016\/j.ijsu.2015.06.087"},{"key":"2025120909254757897_j_pp-2024-0017_ref_027","doi-asserted-by":"crossref","unstructured":"Gustafsson, UO, Hausel, J, Thorell, A, Ljungqvist, O, Soop, M, Nygren, J. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg 2011;146:571\u20137. https:\/\/doi.org\/10.1001\/archsurg.2010.309.","DOI":"10.1001\/archsurg.2010.309"},{"key":"2025120909254757897_j_pp-2024-0017_ref_028","doi-asserted-by":"crossref","unstructured":"Geltzeiler, CB, Rotramel, A, Wilson, C, Deng, L, Whiteford, MH, Frankhouse, J. Prospective study of colorectal enhanced recovery after surgery in a community hospital. JAMA Surg 2014;149:955\u201361. https:\/\/doi.org\/10.1001\/jamasurg.2014.675.","DOI":"10.1001\/jamasurg.2014.675"},{"key":"2025120909254757897_j_pp-2024-0017_ref_029","doi-asserted-by":"crossref","unstructured":"Bisch, SP, Wells, T, Gramlich, L, Faris, P, Wang, X, Tran, DT, et al.. Enhanced recovery after surgery (ERAS) in gynecologic oncology: system-wide implementation and audit leads to improved value and patient outcomes. Gynecol Oncol 2018;151:117\u201323. https:\/\/doi.org\/10.1016\/j.ygyno.2018.08.007.","DOI":"10.1016\/j.ygyno.2018.08.007"},{"key":"2025120909254757897_j_pp-2024-0017_ref_030","doi-asserted-by":"crossref","unstructured":"Pisarska, M, P\u0119dziwiatr, M, Ma\u0142czak, P, Major, P, Ochenduszko, S, Zub-Pokrowiecka, A, et al.. Do we really need the full compliance with ERAS protocol in laparoscopic colorectal surgery? A prospective cohort study. Int J Surg 2016;36:377\u201382. Part A https:\/\/doi.org\/10.1016\/j.ijsu.2016.11.088.","DOI":"10.1016\/j.ijsu.2016.11.088"},{"key":"2025120909254757897_j_pp-2024-0017_ref_031","doi-asserted-by":"crossref","unstructured":"Pache, B, Joliat, GR, H\u00fcbner, M, Grass, F, Demartines, N, Mathevet, P, et al.. Cost-analysis of enhanced recovery after surgery (ERAS) program in gynecologic surgery. Gynecol Oncol 2019;154:388\u201393. https:\/\/doi.org\/10.1016\/j.ygyno.2019.06.004.","DOI":"10.1016\/j.ygyno.2019.06.004"},{"key":"2025120909254757897_j_pp-2024-0017_ref_032","doi-asserted-by":"crossref","unstructured":"Gustafsson, UO, Oppelstrup, H, Thorell, A, Nygren, J, Ljungqvist, O. Adherence to the ERAS protocol is associated with 5-year survival after colorectal cancer surgery: a retrospective cohort study. World J Surg 2016;40:1741\u20137. https:\/\/doi.org\/10.1007\/s00268-016-3460-y.","DOI":"10.1007\/s00268-016-3460-y"},{"key":"2025120909254757897_j_pp-2024-0017_ref_033","doi-asserted-by":"crossref","unstructured":"Vlug, MS, Wind, J, Hollmann, MW, Ubbink, DT, Cense, HA, Engel, AF, et al.. LAFA Study Group. Laparoscopy in combination with fast track multimodal management is the best perioperative strategy in patients undergoing colonic surgery: a randomized clinical trial (LAFA-study). Ann Surg 2011;254:868\u201375. https:\/\/doi.org\/10.1097\/SLA.0b013e31821fd1ce.","DOI":"10.1097\/SLA.0b013e31821fd1ce"},{"key":"2025120909254757897_j_pp-2024-0017_ref_034","doi-asserted-by":"crossref","unstructured":"Vlug, MS, Wind, J, Hollmann, MW, Ubbink, DT, Cense, HA, Engel, AF, et al.. Laparoscopy in combination with fast track multimodal management is the best perioperative strategy in patients undergoing colonic surgery: a randomized clinical trial (LAFA-study). Ann Surg 2011;254:868\u201375. https:\/\/doi.org\/10.1097\/sla.0b013e31821fd1ce.","DOI":"10.1097\/SLA.0b013e31821fd1ce"},{"key":"2025120909254757897_j_pp-2024-0017_ref_035","doi-asserted-by":"crossref","unstructured":"P, SS, R, AK, Kumar, R, Naidu, N, Zaveri, SS, et al.. Standardization of patient selection and hyperthermic intraperitoneal chemotherapy protocol for peritoneal surface malignancy in Indian patients. Indian J Gynecol Oncolog 2017;15:55\u201363. https:\/\/doi.org\/10.1007\/s40944-017-0154-9.","DOI":"10.1007\/s40944-017-0154-9"},{"key":"2025120909254757897_j_pp-2024-0017_ref_036","doi-asserted-by":"crossref","unstructured":"Duzgun, O. Evaluation of enhanced recovery after following a surgical protocol for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Med Arch 2019;73:331\u20137. https:\/\/doi.org\/10.5455\/medarh.2019.73.331-337.","DOI":"10.5455\/medarh.2019.73.331-337"},{"key":"2025120909254757897_j_pp-2024-0017_ref_037","doi-asserted-by":"crossref","unstructured":"Solanki, SL, Mukherjee, S, Agarwal, V, Thota, RS, Balakrishnan, K, Shah, SB, et al.. Society of onco-anaesthesia and perioperative care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian J Anaesth 2019;63:972\u201387. https:\/\/doi.org\/10.4103\/ija.ija_765_19.","DOI":"10.4103\/ija.IJA_765_19"},{"key":"2025120909254757897_j_pp-2024-0017_ref_038","doi-asserted-by":"crossref","unstructured":"Aarts, MA, Rotstein, OD, Pearsall, EA, Victor, JC, Okrainec, A, McKenzie, M, et al.. Postoperative ERAS interventions have the greatest impact on optimal recovery: experience with implementation of ERAS across multiple hospitals. Ann Surg 2018;267:992\u20137. https:\/\/doi.org\/10.1097\/sla.0000000000002632.","DOI":"10.1097\/SLA.0000000000002632"},{"key":"2025120909254757897_j_pp-2024-0017_ref_039","doi-asserted-by":"crossref","unstructured":"Veerapong, J, King, BH, Baumgartner, JM, Kelly, KJ, Lowy, AM, Gabriel, RA. The use of predictive modelling for prolonged hospital length of stay for the development of an enhanced recovery after surgery program for patients undergoing cytoreductive surgery with\/without hyperthermic intra peritoneal chemotherapy. Clin Nutr 2018;25:166\u2013209.","DOI":"10.1016\/j.clnesp.2018.03.063"},{"key":"2025120909254757897_j_pp-2024-0017_ref_040","doi-asserted-by":"crossref","unstructured":"Siddharthan, R, Dewey, E, Billingsley, K, Gilbert, E, Tsikitis, VL. Feasibility and benefits of an enhanced recovery after surgery protocol for patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy: a single institution experience. Am J Surg 2020;219:1073\u20135. https:\/\/doi.org\/10.1016\/j.amjsurg.2019.06.019.","DOI":"10.1016\/j.amjsurg.2019.06.019"},{"key":"2025120909254757897_j_pp-2024-0017_ref_041","doi-asserted-by":"crossref","unstructured":"Feroci, F, Lenzi, E, Baraghini, M, Garzi, A, Vannucchi, A, Cantafio, S, et al.. Fast- track colorectal surgery: protocol adherence influences postoperative out- comes. Int J Colorectal Dis 2012;28:103e109. https:\/\/doi.org\/10.1007\/s00384-012-1569-5.","DOI":"10.1007\/s00384-012-1569-5"},{"key":"2025120909254757897_j_pp-2024-0017_ref_042","doi-asserted-by":"crossref","unstructured":"Alcantara-Moral, M, Serra-Aracil, X, Gil-Egea, MJ, Frasson, M, Flor-Lorente, B, Garcia-Granero, E, et al.. Observational cross-sectional study of compliance with the fast track protocol in elective surgery for colon cancer in Spain. Int J Colorectal Dis 2014;29:477\u201383. https:\/\/doi.org\/10.1007\/s00384-013-1825-3.","DOI":"10.1007\/s00384-013-1825-3"},{"key":"2025120909254757897_j_pp-2024-0017_ref_043","doi-asserted-by":"crossref","unstructured":"Greco, M, Capretti, G, Beretta, L, Gemma, M, Pecorelli, N, Braga, M. Enhanced recovery program in colorectal surgery: a meta- analysis of randomized controlled trials. World J Surg 2014;38:1531\u201341. https:\/\/doi.org\/10.1007\/s00268-013-2416-8.","DOI":"10.1007\/s00268-013-2416-8"},{"key":"2025120909254757897_j_pp-2024-0017_ref_044","doi-asserted-by":"crossref","unstructured":"Kummer, A, Slieker, J, Grass, F, Hahnloser, D, Demartines, N, H\u00fcbner, M. Enhanced recovery pathway for right and left colectomy: comparison of functional recovery. World J Surg 2016;40:2519\u201327. https:\/\/doi.org\/10.1007\/s00268-016-3563-5.","DOI":"10.1007\/s00268-016-3563-5"},{"key":"2025120909254757897_j_pp-2024-0017_ref_045","doi-asserted-by":"crossref","unstructured":"Iniesta, MD, Lasala, J, Mena, G, Rodriguez-Restrepo, A, Salvo, G, Pitcher, B, et al.. Impact of compliance with an enhanced recovery after surgery pathway on patient outcomes in open gynecologic surgery. Int J Gynecol Cancer 2019;29:1417\u201324. https:\/\/doi.org\/10.1136\/ijgc-2019-000622.","DOI":"10.1136\/ijgc-2019-000622"},{"key":"2025120909254757897_j_pp-2024-0017_ref_046","doi-asserted-by":"crossref","unstructured":"Carmichael, JC, Keller, DS, Baldini, G, Bordeianou, L, Weiss, E, Lee, L, et al.. Clinical practice guidelines for enhanced recovery after colon and rectal surgery from the American society of colon and rectal surgeons and society of American gastrointestinal and endoscopic surgeons. Dis Colon Rectum 2017;60:761\u201384. https:\/\/doi.org\/10.1097\/dcr.0000000000000883.","DOI":"10.1097\/DCR.0000000000000883"},{"key":"2025120909254757897_j_pp-2024-0017_ref_047","doi-asserted-by":"crossref","unstructured":"Puleo, F, Mishra, N, Hall, J. Use of intra-abdominal drains. Clin Colon Rectal Surg 2013;26:174\u20137. https:\/\/doi.org\/10.1055\/s-0033-1351134.","DOI":"10.1055\/s-0033-1351134"},{"key":"2025120909254757897_j_pp-2024-0017_ref_048","doi-asserted-by":"crossref","unstructured":"Mujagic, E, Zeindler, J, Coslovsky, M, Hoffmann, H, Soysal, SD, Mechera, R, et al.. The association of surgical drains with surgical site infections\u00a0\u2013\u00a0a prospective observational study. Am J Surg 2019;217:17\u201323. https:\/\/doi.org\/10.1016\/j.amjsurg.2018.06.015.","DOI":"10.1016\/j.amjsurg.2018.06.015"},{"key":"2025120909254757897_j_pp-2024-0017_ref_049","doi-asserted-by":"crossref","unstructured":"Alyami, M, Kim, BJ, Villeneuve, L, Vaudoyer, D, K\u00e9p\u00e9n\u00e9kian, V, Bakrin, N, et al.. Ninety-day post-operative morbidity and mortality using the National Cancer Institute\u2019s common terminology criteria for adverse events better describe post-operative outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Int J Hyperther 2018;34:532\u20137. https:\/\/doi.org\/10.1080\/02656736.2017.1367846.","DOI":"10.1080\/02656736.2017.1367846"},{"key":"2025120909254757897_j_pp-2024-0017_ref_050","doi-asserted-by":"crossref","unstructured":"Padmakumar, AV. Intensive care management of patient after cytoreductive surgery and HIPEC\u00a0\u2013\u00a0a concise review. Indian J Surg Oncol 2016;7:244\u20138. https:\/\/doi.org\/10.1007\/s13193-016-0511-7.","DOI":"10.1007\/s13193-016-0511-7"},{"key":"2025120909254757897_j_pp-2024-0017_ref_051","doi-asserted-by":"crossref","unstructured":"Lyon, A, Solomon, MJ, Harrison, JD. A qualitative study assessing the barriers to implementation of enhanced recovery after surgery. World J Surg 2014;38:1374\u201380. https:\/\/doi.org\/10.1007\/s00268-013-2441-7.","DOI":"10.1007\/s00268-013-2441-7"},{"key":"2025120909254757897_j_pp-2024-0017_ref_052","doi-asserted-by":"crossref","unstructured":"Francis, N, Kennedy, RH, Ljungqvist, O, Mythen, MG. Manual of fast track recovery for colorectal surgery. Berlin, Germany: Springer Science & Business Media; 2012.","DOI":"10.1007\/978-0-85729-953-6"},{"key":"2025120909254757897_j_pp-2024-0017_ref_053","doi-asserted-by":"crossref","unstructured":"Pasero, C, Belden, J. Evidence-based perianesthesia care: accelerated post- operative recovery programs. J.\u00a0Perianesth. Nurs. 2006;21:168\u201376. https:\/\/doi.org\/10.1016\/j.jopan.2006.03.010.","DOI":"10.1016\/j.jopan.2006.03.010"},{"key":"2025120909254757897_j_pp-2024-0017_ref_054","doi-asserted-by":"crossref","unstructured":"Egbert, LD, Battit, GE, Welch, CE, Bartlett, MK. Reduction of postoperative pain by encouragement and instruction of patients. A study of doctor-patient rapport. N\u00a0Engl J Med 1964;270:825\u20137. https:\/\/doi.org\/10.1056\/NEJM196404162701606.","DOI":"10.1056\/NEJM196404162701606"},{"key":"2025120909254757897_j_pp-2024-0017_ref_055","doi-asserted-by":"crossref","unstructured":"Kehlet, H, Wilmore, DW. Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008;248:189e198. https:\/\/doi.org\/10.1097\/SLA.0b013e31817f2c1a.","DOI":"10.1097\/SLA.0b013e31817f2c1a"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2024-0017\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2024-0017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:05:31Z","timestamp":1765278331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2024-0017\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4,24]]},"published-print":{"date-parts":[[2025,6,20]]}},"alternative-id":["10.1515\/pp-2024-0017"],"URL":"https:\/\/doi.org\/10.1515\/pp-2024-0017","relation":{},"ISSN":["2364-768X"],"issn-type":[{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]}}}